Conversely, of the 511 CSRs overexpressed in breast tumours relative to healthy breast tissue, 72 were significantly underexpressed when compared to non-breast healthy tissues, including well-established drug targets like FGFR3, CD48, and CCR3 (Fig 2F). This evidence concerns the gene CCR3 and breast neoplasm.